|
||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
By

From the * Laboratory of Immunology, Division of Hematologic Products, Center for Biologics
Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20852; and While it is generally believed that the avidity of the T cell antigen receptor (TCR) for self antigen/major histocompatibility complex (MHC) determines a thymocyte's fate, how the cell
discriminates between a stimulus that causes positive selection (survival) and one that causes
negative selection (death) is unknown. We have previously demonstrated that glucocorticoids
are produced in the thymus, and that they antagonize deletion caused by TCR cross-linking. To examine the role of glucocorticoids during MHC-dependent selection, we examined thymocyte development in organ cultures in which corticosteroid biosynthesis was inhibited. Inhibition of glucocorticoid production in thymi from
Laboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health,
Bethesda, Maryland 20892-1152
/
-TCR transgenic mice resulted in the
antigen- and MHC-specific loss of thymocytes that normally recognize self antigen/MHC
with sufficient avidity to result in positive selection. Furthermore, inhibition of glucocorticoid
production caused an increase in apoptosis only in CD+CD8+ thymocytes bearing transgenic
TCRs that recognized self antigen/MHC. These results indicate that the balance of TCR and
glucocorticoid receptor signaling influences the antigen-specific thymocyte development by allowing cells with low-to-moderate avidity for self antigen/MHC to survive.
This article has been cited by other articles:
| TABLE OF CONTENTS |
|